• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

12/14/2018/by CAPTIS

Wright Medical loses bid for legal fees in Spineology patent spat

The U.S. Court of Appeals for the Federal Circuit this week…
12/14/2018/by CAPTIS

Early stage ortho company Edge Surgical raises $4m

12/14/2018/by CAPTIS

Magnetic Insight raises $18m in Series A

12/14/2018/by CAPTIS

Gerresheimer taps Metzner as CFO | Personnel Moves – December 14, 2018

12/14/2018/by CAPTIS

Renerva lands $2.4 million to develop ‘Neosporin of nerve repair’

12/14/2018/by CAPTIS

MiMedx escapes Osiris trade theft suit

12/14/2018/by CAPTIS

Moody’s: Outlook strong for medical devices in 2019

12/14/2018/by CAPTIS

Will Acelity go public again?

12/14/2018/by CAPTIS

Tidepool raises $6m to develop automated insulin delivery app

12/14/2018/by CAPTIS

Here’s how Intuitive Surgical is innovating to stay competitive

12/14/2018/by CAPTIS

Conformis to lay of 10% of workforce

ConforMIS (NSDQ:CFMS) said yesterday that it plans to lay…
12/14/2018/by CAPTIS

Bausch Health signs stalking horse agreement to buy Synergy Pharmaceuticals

12/14/2018/by CAPTIS

Novartis gets EC approval for self-administration of Xolair across all indications

12/13/2018/by CAPTIS

AMAG Pharmaceuticals to buy biopharmaceutical firm Perosphere

12/13/2018/by CAPTIS

ConMed to acquire Buffalo Filter for $365m

12/13/2018/by CAPTIS

FDA: GE R860 ventilator safety guard recall is Class I

12/13/2018/by CAPTIS

Edwards to add 370 employees in Costa Rica

12/13/2018/by CAPTIS

Acute decompensated HF treatment device dev WhiteSwell raises $30m in Series B

12/13/2018/by CAPTIS

Check-Cap wins conditional IDE approval for C-Scan pilot study

12/13/2018/by CAPTIS

Report: Apple hiring dozens of MDs, solidifies venture into healthcare

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

Hologic touts win in trade secret case

0 Comments
/
12/13/2018
Hologic (NSDQ:HOLX) yesterday touted a win in a court case…
Read more
https://www.captis.com/wp-content/uploads/2018/12/justice-gavel-multiuse-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-13 06:58:262018-12-13 08:01:30Hologic touts win in trade secret case

Bovie to rebrand as Apyx Medical, move to NASDAQ

0 Comments
/
12/13/2018
Bovie Medical (NYSE:BVX) said yesterday that it plans to…
Read more
https://www.captis.com/wp-content/uploads/2018/12/bovie-medical-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-13 05:50:392018-12-13 07:01:32Bovie to rebrand as Apyx Medical, move to NASDAQ

Report: J&J willing to pay more than $400m to settle Pinnacle hip cases

0 Comments
/
12/13/2018
Johnson & Johnson (NYSE:JNJ) is willing to put more…
Read more
https://www.captis.com/wp-content/uploads/2018/12/johnson-johnson-multiuse-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-13 05:31:142018-12-13 07:01:29Report: J&J willing to pay more than $400m to settle Pinnacle hip cases

X-Chem, Almirall forge dermatology-focused drug discovery alliance

0 Comments
/
12/13/2018
Under the terms of the agreement, X-Chem will utilize its industry-leading…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-13 02:31:092018-12-13 03:31:10X-Chem, Almirall forge dermatology-focused drug discovery alliance

Weizmann researchers discover new neural mechanism underlying anxiety

0 Comments
/
12/13/2018
Targeting this biochemical pathway may help develop new therapies…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-13 02:31:072018-12-13 03:31:08Weizmann researchers discover new neural mechanism underlying anxiety

Ra Pharma’s zilucoplan meets primary endpoints in phase 2 gMG trial

0 Comments
/
12/13/2018
Zilucoplan, which is a synthetic, macrocyclic peptide, achieved…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-13 02:31:052018-12-13 03:31:06Ra Pharma’s zilucoplan meets primary endpoints in phase 2 gMG trial

Janssen’s Tremfya meets primary endpoint in phase 3 psoriasis trial

0 Comments
/
12/13/2018
The phase 3 trial, called ECLIPSE, enrolled 1048 patients to…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-13 00:31:062018-12-13 01:31:07Janssen’s Tremfya meets primary endpoint in phase 3 psoriasis trial

UK preparing for ‘worst-case’ medical supply Brexit plan

0 Comments
/
12/12/2018
The UK government is preparing for a “worst-case”…
Read more
https://www.captis.com/wp-content/uploads/2018/12/brexit-multiuse-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-12 10:44:362018-12-12 12:01:23UK preparing for ‘worst-case’ medical supply Brexit plan

Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018

0 Comments
/
12/12/2018
Sanuwave said late last month that it lifted acting CEO and…
Read more
https://www.captis.com/wp-content/uploads/2018/12/sanuwave-kevin-richardson-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-12 08:57:282018-12-12 10:01:17Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018

Appeals court OKs $248m Stryker win over Zimmer Biomet

0 Comments
/
12/12/2018
The U.S. Court of Appeals for the Federal Circuit this week…
Read more
https://www.captis.com/wp-content/uploads/2018/12/stryker-biomet-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-12 07:35:542018-12-12 09:01:19Appeals court OKs $248m Stryker win over Zimmer Biomet

Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery

0 Comments
/
12/12/2018
The joint team is focused on the discovery of efficacious inhibitors…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-12 03:01:522018-12-12 04:01:53Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery

Versant Ventures launches new biotech firm Black Diamond Therapeutics

0 Comments
/
12/12/2018
Black Diamond is the first company launched out of Ridgeline,…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-12 01:03:092018-12-12 02:03:10Versant Ventures launches new biotech firm Black Diamond Therapeutics

Circassia to acquire full US rights of AstraZeneca’s COPD treatment Tudorza

0 Comments
/
12/11/2018
Circassia has issued a notice of option exercise to AstraZeneca…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 23:31:052018-12-12 00:31:08Circassia to acquire full US rights of AstraZeneca’s COPD treatment Tudorza

Boston Scientific touts win in continued TAVR patent spat with Edwards Lifesciences

0 Comments
/
12/11/2018
Boston Scientific (NYSE:BSX) today claimed a win in an…
Read more
https://www.captis.com/wp-content/uploads/2018/12/edwards-boston-scientific-multiuse-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 15:02:202018-12-11 16:31:11Boston Scientific touts win in continued TAVR patent spat with Edwards Lifesciences

Seisa Medical, CA attorney settle alleged $2m fraud suit

0 Comments
/
12/11/2018
Seisa Medical has settled a case against an allegedly fraudulent…
Read more
https://www.captis.com/wp-content/uploads/2018/12/saisa-medical-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 13:43:362018-12-11 15:01:44Seisa Medical, CA attorney settle alleged $2m fraud suit

Strata Skin Sciences adds license for excimer laser vitiligo treatment 

0 Comments
/
12/11/2018
Strata Skin Sciences (NSDQ:SSKN) said it has reached an agreement…
Read more
https://www.captis.com/wp-content/uploads/2018/12/Strata-Skin-Sciences-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 11:01:532018-12-11 12:31:59Strata Skin Sciences adds license for excimer laser vitiligo treatment 

Seno Medical Instruments touts Imagio breast cancer subtype ID trial results

0 Comments
/
12/11/2018
Seno Medical Instruments today released results from a study…
Read more
https://www.captis.com/wp-content/uploads/2018/12/seno-medical-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 10:57:472018-12-11 12:01:18Seno Medical Instruments touts Imagio breast cancer subtype ID trial results

LumiThera inks Italian Valeda distro deal

0 Comments
/
12/11/2018
LumiThera said today that it inked a deal with ophthalmology…
Read more
https://www.captis.com/wp-content/uploads/2018/12/lumithera-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 10:33:162018-12-11 12:01:15LumiThera inks Italian Valeda distro deal

BioCardia submits bid for FDA clearance of Avance transseptal introducer

0 Comments
/
12/11/2018
BioCardia (NSDQ:BCDA) said today that it submitted an application…
Read more
https://www.captis.com/wp-content/uploads/2018/12/biocardia-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 10:17:322018-12-11 11:31:14BioCardia submits bid for FDA clearance of Avance transseptal introducer

Report: India still lacks solid medical device regulation

0 Comments
/
12/11/2018
It has been 13 years since Indian health authorities were directed…
Read more
https://www.captis.com/wp-content/uploads/2018/12/india-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 09:51:232018-12-11 11:01:27Report: India still lacks solid medical device regulation
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
American College of Cardiology
American College of Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Fundamental Surgery
Fundamental Surgery
@FundamentalSurg

We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…

reply retweet favorite
4:41 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
K2M, Inc. Jobs
K2M, Inc. Jobs
@K2MIncJobs

Congratulations to Lane Major for his recent promotion to Chief Operating Officer @K2MInc! Read more: bit.ly/LaneMajor pic.twitter.com/iDXk…

reply retweet favorite
12:45 pm · 03/31/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
José Luis Maçãs
José Luis Maçãs
@zeluismacas

Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…

reply retweet favorite
11:29 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
SOFCOT
SOFCOT
@sofcot_ortho

Thème du congrès SOFCOT 2018 : "La Décision Médicale" pic.twitter.com/hJT5…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
EUROSPINE
EUROSPINE
@EUROSPINESoc

Exactly 3 weeks left to submit your abstract for #EUROSPINE2018 - #deadline 1 March 2018 #research #spine #SpineResearch #spineSurgery #SpinalDisorder #ScientificPaper #BasicScience #ClinicalResearch #PublishResearch @EurSpineJournal buff.ly/2ExMQ7e pic.twitter.com/Fx2Q…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
Olea Medical
Olea Medical
@OleaMedical

Throughout the week, we are in #Bruges alongside Prof. Jan Casselman for an #Erasmus course program on #ENT imaging, held at the Oud Sint-Jan congress centre. The training of around 170 radiologists is based on images from our post-processing solution Olea Sphere®V3.0. #MRI pic.twitter.com/KSUU…

reply retweet favorite
11:24 am · 02/10/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top